Medexus Announces US$51.0 million in New Credit Facilities and Intention to Commence Normal Course Issuer Bid, or NCIB, for its Common Shares
PharmaTher Advances Strategy to Build Next-Generation Ketamine Franchise for Neuropsychiatric Disorders; Secures Exclusive Rights to Evaluate and License Patented Long-Acting Ketamine Program
HCA HealthONE Rose First in Colorado to Adopt Perimeter's Advanced OCT Imaging Technology for Use in Surgery
Theralase(R) Investor Conference Call Reminder
Algernon Health and American Molecular Imaging Announce Strategic Business and USD $500K Investment Agreement
Bright Minds Biosciences Expands Scientific Advisory Board to Include Renowned Experts in Prader-Willi Syndrome (PWS)
Nxera Announces Focused Restructuring to Enhance Path to Profitability
Algernon closes $177,000 first tranche of financing
Algernon Closes First Tranche of its Recently Announced Private Placement Financing
Pangea Natural Foods files amended financials, MD&A
Betterlife director Beaudry resigns; arranges debt deal
COSCIENS Biopharma Inc. Announces Leadership Change
Satellos spends $4M (U.S.) on R&D in Q3 2025
Satellos Reports Third Quarter 2025 Results and Announces Appointment of Mark Nawacki to Board of Directors
Fennec Pharmaceuticals Announces Private Offering of Common Shares in Canada